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Abstract
Objectives: To conduct a geographically defined, UK-based case-control study, to examine any association between physical
activity (PA) and amyotrophic lateral sclerosis (ALS). Methods: A novel historical PA questionnaire was designed, validated,
and subsequently administered in individual face-to-face interviews of 175 newly diagnosed sporadic ALS cases and 317
age- and sex-matched community controls. Historical PA energy expenditure and time spent in vigorous-intensity PA were
derived from questionnaire data and compared between cases and controls. Results: Participation in an extra 10kJ/kg/day of
PA (equivalent to approximately 45minutes brisk walking) was consistently associated with an increased risk of ALS, with
the strongest association observed for adulthood exercise-related PA (OR 1.47, 95% CI 1.10-1.97). An extra 10mins/day of
vigorous PA was also associated with the odds of ALS (OR 1.03, 95% CI 101-105). Results were slightly attenuated
following adjustment for smoking and educational attainment. Conclusions: To our knowledge this is the first study to
demonstrate a positive association between ALS and PA participation using a specifically designed and validated historical
PA questionnaire. Despite the well-established health benefits of PA, a high activity lifestyle may also be associated with
elevated risk of ALS. Large-scale prospective studies in the future may help to confirm this association.
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Introduction
Amyotrophic lateral sclerosis (ALS) is a disabling,
terminal neurodegenerative condition characterised
by progressive paralysis and atrophy of limb, bulbar
and ultimately respiratory muscles. Population-
based research demonstrates geographical variation
in incidence, with an annual incidence in Europe
and North America of approximately 2 per 100,000
(1,2) and lower incidence suggested in African,
Asian and Hispanic populations (3).
Epidemiological, biological and genetic research
suggests a complex pathogenic interaction between
genetic and environmental exposures (4). However,
aside from inherent risk associated with genotype,
age and gender, very few exogenous causative
factors have been confirmed. The strongest evidence
relates to smoking, which was associated with
incident ALS in a recent meta-analysis of prospect-
ive studies including over 1 million participants (5).
Following proposals of an association between
physical activity (PA) and the development of ALS
(6), several observational studies have examined this
hypothesis, with inconsistent results (7–11). Reports
of elevated ALS incidence in Italian professional
footballers stimulated further epidemiological
research (12–14). However, methodological chal-
lenges when examining exogenous associations with
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relatively rare diseases, particularly regarding sample
size, bias minimisation, and valid exposure quanti-
fication, have limited the conclusions drawn, though
recent studies have improved on some of these
concerns (15,16).
Beyond epidemiology, it has been proposed that
elevated tissue metabolism and motor neuron firing
during exercise augment oxidative stress and glu-
tamate excitotoxicity-related motor neuron degen-
eration (17,18). Several genes associated with ALS
are also known to be up-regulated by PA (19,20).
Homeostatic abnormalities in ALS which may
respond to PA participation provide an alternative
mechanism for a disease association (21).
We hypothesised that participation in a high level
of PA is associated with an increased risk of sporadic
ALS. Our objectives were to conduct a case-control
study, recruiting a UK-based study population, to
determine any association between PA and ALS.
Materials and Methods
ALS patients and community controls were
recruited between July 2009 and July 2013 from a
geographically defined population within Northern
England comprising approximately 76 million indi-
viduals. Relevant NHS and university research
ethical approvals were obtained and procedures
followed were in accordance with these standards.
All study participants provided informed consent.
Study population
Individuals with clinically definite, probable or
possible sporadic ALS (22), were identified from
hospital and community ALS services. Patients were
eligible if recruited within 6 months of diagnosis to
ensure near-incident rather than long-prevalent
cases. Those with any family history of ALS or
concurrent neurodegenerative disease were
excluded. Potential controls were identified from a
selection of general medical practices within the
same regions, covering a broad spectrum of patient
demographics. To recruit two controls per case, 10
individuals without an active neurological diagnosis,
and matched to each case by date of birth (+/-5
years) and gender, were randomly selected for
invitation by their general practitioners. All eligible
participants were sent written information about the
study, and individual appointments arranged with
those who decided to participate.
Data collection
Face-to-face interviews, lasting approximately
90 minutes, were conducted with each participant
by one of two interviewers, using a standardised
approach. PA data were collected using a novel,
valid electronic questionnaire, the Historical
Adulthood Physical Activity Questionnaire
(HAPAQ)(23). In brief, HAPAQ collects data
regarding total adulthood PA at home, work and in
leisure (exertional sport and casual exercise). Closed
questions regarding the nature, frequency and
duration of activities are asked in periods of 5 or
10 years, using a life calendar of significant events to
aid recall. Participants were blinded to the research
hypothesis.
Data reduction from the questionnaire
To quantify PA volume, PA energy expenditure
(PAEE) scores for each activity were derived from
questionnaire data using the Compendium of
Physical Activities (24). This resource quantifies
the energy expenditure of activities as a ratio with
standard resting metabolic rate, expressed as meta-
bolic equivalents (METs), with one METequivalent
to an approximate oxygen consumption of 35ml
O2/kg/min. MET intensity values for each reported
activity were identified from the Compendium,
subtracted by 1 MET for resting metabolic rate,
and then multiplied by the reported activity dur-
ations. The average daily PAEE (kJ/kg/day) was
calculated using the following equation, assuming
the energy equivalent of one litre of oxygen to be
203kJ (25):
Self - report PAEE ¼ Duration Activityi
 ðMET scorei1Þ  3:5 20:3
Individual average daily PAEEs from occupa-
tional, leisure and total PA were summarised for the
most recent 15 years, reflecting the period HAPAQ
was validated, and for the whole of adulthood. The
time spent in vigorous PA, defined as intensity 6.0
METs, was also determined (26). Data for the most
recent five years were excluded to limit PA suppres-
sion which might result from subclinical disease.
When calculating total volume of PA, housework-
related activity was excluded, following observations
of an inverse association of self-reported housework
with objectively assessed PAEE (27).
Statistical analysis
To detect an odds ratio (OR) of 1.8, at 80% power
and an alpha value of 0.05, 175 cases and 350
controls were required to compare participants in
the highest quartile of total PAEE with those below
the 75th centile.
STATA/IC version 130 statistical package was
used for the analyses. Baseline participant charac-
teristics were tabulated by case status. Separate
conditional logistic regression models determined
the independent ORs for the association between
ALS and several PA exposure variables: average
daily total PA, time spent in vigorous PA, and
activity during leisure and work. Adjustment was
made for age as a continuous variable based on
knowledge of greater ALS risk with increasing age,
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evidence of a negative correlation between age and
PA in the study population, and plausibility of a
confounding role. As evidence regarding the associ-
ation of smoking with ALS remains inconclusive, we
present both adjusted and unadjusted models with
regards to smoking (5,28). Further adjustment was
made for educational attainment (school only or
professional/vocational qualification or university
qualification). We also examined the association
between age of onset of ALS (cases) or recruitment
(controls) and PA participation using a linear
regression model, formally tested using an inter-
action term between PA and case status.
Results
424 MND patients were screened for the study.
Figure 1 describes the case selection process. Of
those screened, 146 patients did not meet the
eligibility criteria or lived outside the recruitment
area. 34 eligible patients were too unwell or
emotionally distressed to approach regarding
research participation. From the remaining 244
patients, 175 were recruited. Regarding controls,
all those agreeing to participate and able to attend
an interview within the study timeframe, were
recruited. Every consented participant completed
the data collection process, with no missing data for
any variables.
Table 1 displays the baseline characteristics of
the participants. 68% of cases had clinically definite
or probable ALS. Almost 70% of cases presented
with limb-onset disease and 28% with bulbar-onset.
Cases and controls were similar regarding age,
gender, smoking status and education. Within the
most recent 15 years, 28.3% of controls and 30.1%
of ALS cases had retired from work.
ALS cases consistently reported higher total PA,
time spent in vigorous PA and PA in work and
leisure compared to controls (Table 2 and Figure 2).
However, the range of reported PA was wide and
overlapping for both sets of participants. Regarding
Figure 1. Selection process for recruitment.
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domain-specific activity, 334% controls and 309%
cases reported no adulthood sport participation,
reflected by the lower limit of the related interquar-
tile ranges in Table 2. When comparing the two time
periods, 448% of controls and 429% of cases
reported no vigorous PA during the last 15 years
compared to 202% and 143% respectively
throughout the whole of adulthood.
Table 3 reports the ORs regarding the associ-
ation between PA participation and ALS status.
A difference in daily PAEE of 10kJ/kg, equivalent to
approximately 45 minutes of brisk walking or
20 minutes of soccer, was consistently associated
with an increase in the odds of having ALS.
Significantly positive associations were demon-
strated for both time periods and across most PA
domains. The strongest association related to par-
ticipation in higher levels of adulthood casual
exercise PA (age adjusted OR 147, 95% CI 110-
197, p ¼ 0.01). Total PA throughout adulthood was
also significantly associated with ALS (age adjusted
OR 109, 95% CI 103–116, p ¼ 0.002), as was
undertaking an extra 10 minutes of vigorous PA per
day (age adjusted OR 103, 95% CI 101–105, p ¼
Table 1. Demographic and clinical characteristics of study participants. Quantitative values are given as
medians (interquartile range) or n (%).
Variable Controls (n¼ 317) Cases (n¼175)
Basic demographics
Number of males (%) 197 (622) 109 (623)
Age (years) 65 (full range 36-91) 64 (full range 26-88)
Retired in last 15 years, n (%) 269 (283) 158 (301)
El-Escorial diagnostic criteria
Clinically definite, n (%) 45 (257)
Clinically probable, n (%) 74 (423)
Clinically probable lab-supported, n(%) 43 (246)
Clinically possible, n (%) 13 (74)
Site of onset
Lower limb, n (%) 57 (326)
Upper limb, n (%) 65 (371)
Bulbar, n (%) 49 (280)
Respiratory, n (%) 4 (23)
Smoking status
Non-smoker, n (%) 86 (271) 50 (286)
Ex-smoker, n (%) 199 (628) 108 (617)
Current smoker, n (%) 32 (101) 17 (97)
Education
Age left fulltime education (years) 16 (full range 12-35) 16 (full range 12-25)
School education only, n (%) 90 (284) 62 (354)
Professional/vocational qualification, n (%) 147 (464) 84 (480)
University qualification, n (%) 80 (25.2) 29 (16.6)
Table 2. Self-reported physical activity (PA) exposure by participants.
Physical activity (PA) variable
Controls (n¼ 317) Cases (n¼175)
Median IQR Median IQR
Average daily PA during the last 5–15 years
Total PA (kJ/kg/day) 431 271–686 486 277–760
Time spent in PA46METs (mins/day) 2.4 00–24.0 4.2 00–36.0
Work related PA (kJ/kg/day) 247 119–467 275 96–549
Total leisure PA (kJ/kg/day) 110 40–210 132 46–275
Exertional sport related PA# (kJ/kg/day) 00 00–73 00 00–98
Casual exercise related PA+ (kJ/kg/day) 55 22–122 84 31–159
Average daily adulthood PA
Total PA (kJ/kg/day) 489 326–716 575 352–987
Time spent in PA46METs (mins/day) 9.6 06–30.6 13.2 1.2–744
Work related PA (kJ/kg/day) 331 215–565 373 225–743
Total leisure PA (kJ/kg/day) 91 40–182 108 46–223
Exertional sport related PA (kJ/kg/day) 22 00–96 24 00–110
Casual exercise related PA (kJ/kg/day) 43 18–87 57 25–105
IQR: Interquartile range
#Exertional sport related PA: sporting activities causing sweating and breathlessness
+Casual exercise related PA: regular gentle exercise without causing sweating and breathlessness
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0.004). Further adjustment for both smoking and
educational attainment resulted in only very minor
attenuation of the observed size of effects.
Adulthood exertional sport related activity and
work related activity within the most recent
15 years were not significantly associated with
ALS, possibly reflecting a reduction in power from
the smaller domain-specific sample sizes described
above.
An earlier age of disease onset was observed
with increasing adulthood PA participation. Age
of onset was 034 years (95% CI 0677 to
0002) lower for every additional 10kJ/kg/day of
total PAEE (p¼ 0049) and 064 years (95% CI
-1392 to 0112) lower for an extra hour of
vigorous PA daily (p¼ 0095). In comparison, age
at recruitment of the controls was 0.43 years
(95% CI 0.728 to 0.124) lower for every
additional 10kJ/kg/day of total PAEE (p¼ 0006)
and 0.86 years (95% CI 1.584 to 0.134)
lower for an extra hour of vigorous PA daily
(p¼ 0020). There was no significant interaction
of the effects of age on PA by case status
(p¼ 0.719).
Discussion
To the best of our knowledge, this is the first study
to use a specifically designed and validated PA
questionnaire to demonstrate a positive association
between PA and the development of sporadic ALS.
Positive associations were reported for all domains
of PA and both time periods, and remained follow-
ing adjustment for potential confounders, with the
strongest associations for those reporting higher
levels of exercise-related PA throughout adulthood.
However, our results do not support an earlier age of
onset of ALS with greater PA participation as a
similar age-related association was also demon-
strated within the control group, reflecting a uni-
versal decline in PA participation with increasing
age.
Our findings are in agreement with several
published studies. ALS has been reported as
associated with participation in various domains of
PA, including soccer, leisure activities and varsity
athletics (8,12,14,29). Conversely, some studies
have reported no association (7,9,10). Regardless
of the findings, all the previous studies have
Table 3. Odds ratios for the association of physical activity (PA) with MND per unit change of 10 kJ/kg/day of PA or 10 mins/day of time
spent in vigorous PA.
Physical activity (PA) variable Odds ratio* (95% CI) p value Odds ratioy (95% CI) p value
Average daily PA in last 5–15 years (kJ/kg/day)
Total PA 105 (100–111) 0038 1.04 (0.99–1.10) 0.084
Time spent in PA46METs (mins/day) 102 (1.00–104) 0071 1.01 (0.99–1.03) 0.141
Work related PA 103 (098–109) 0259 1.02 (0.97–1.08) 0.434
Total leisure PA 119 (105–134) 0006 1.19 (1.04–1.35) 0.008
Exertional sport related PA 112 (097–129) 0132 1.12 (0.97–1.31) 0.131
Casual exercise related PA 130 (108–157) 0007 1.28 (1.06–1.55) 0.011
Average daily adulthood PA (kJ/kg/day)
Total PA 109 (103–116) 0002 1.08 (1.02–1.15) 0.009
Time spent in PA46METs (mins/day) 103 (101–105) 0004 1.03 (1.01–1.05) 0.013
Work related PA 109 (103–116) 0006 1.08 (1.01–1.15) 0.021
Total leisure PA 117 (100–137) 0056 1.15 (0.98–1.36) 0.089
Exertional sport related PA 106 (088–127) 0539 1.04 (0.87–1.26) 0.660
Casual exercise related PA 147 (110–197) 0010 1.45 (1.08–1.96) 0.014
*Adjusted for age as a continuous variable
yAdjusted for smoking and education as categorical variables
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Figure 2. Self-reported median daily physical activity (PA) exposure (kj/kg/day) by outcome.
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methodological limitations, particularly relating to
recruitment strategy and the quality of the exposure
data, restricting the conclusions which can be drawn.
Interestingly, a difference in risk between soccer
(elevated) and other sports such as cycling and
basketball (lower) has been described, resulting in
proposals of soccer-specific risk factors rather than
PA participation per se, though small cohort sample
sizes may also explain these observations (30).
Contrasting results have been reported from two
recent case-control studies: a Dutch study, demon-
strating a positive association between ALS and
leisure PA but no other associations, and a European
study, reporting a potential protective effect of PA
relating to the development of ALS (15,16).
Strengths of these studies include population-
based recruitment and large sample sizes.
However, both studies reported either missing data
or proxy informants for around 18% participants,
blinding procedures were not described in the
European study, and neither study described validity
of the exposure assessment, making interpretation of
their results more difficult.
A recent systematic review of epidemiological
studies examining the association between PA and
ALS concluded that PA was not a risk factor, but
was inconclusive regarding the risk associated with
occupational activity and soccer (31). Although
useful criteria were applied to classify the reviewed
evidence, these criteria do not consider the validity
of exposure quantification, a key element in deter-
mining data quality (32). The review also acknowl-
edged significant variation in PA quantification
methodology and resultant accuracy, suggesting
this may contribute to inconsistent findings, such
as the contrasting conclusions in the two recent
studies (15,16). The use of a validated instrument in
the current study goes some way towards addressing
this limitation (23), although it should be noted that
lack of validation of other instruments does not
necessarily imply poor validity.
Geographically-defined variations in genetic sus-
ceptibility and exposure status may also contribute
to reported discrepancies between studies.
Differences in ALS susceptibility gene mutations
between populations are recognised, as illustrated by
variable prevalence of superoxide dismutase-1
(SOD1) mutations in different countries (33).
Work, leisure and transport-related PA patterns are
also likely to differ between countries, raising
questions regarding whether relative PA participa-
tion or a threshold level is aetiologically relevant.
The reported associations with total PAEE in the
present study suggest that overall cumulative PA
participation may be relevant in the pathogenesis of
ALS. Any associations between ALS and PA most
likely represent interactions between genetically
determined susceptibility and exposure to poten-
tially modifiable lifestyle behaviours. Various mech-
anisms have been proposed to explain such a gene-
environment interaction. As normal physiological
responses to PA may interact with several patho-
genic mechanisms relevant to ALS, exercise might
act as a trigger for ALS, with neurodegenerative
consequences in those susceptible to the effects.
Alternatively, individuals may be unable to mount
the normal physiological protective responses to PA,
such as the compensatory rise in antioxidant cap-
acity (34), due to genetic variations which simul-
taneously contribute to the pathogenesis of ALS. A
particular genetic profile may also contribute to
sporting ability and ALS propensity (35), simultan-
eously increasing ALS risk and PA participation.
This would be consistent with reports of lower
weight and reduced cardiovascular morbidity in
ALS patients, which may confound this ALS asso-
ciation (8,36). Also, hypermetabolism has been
demonstrated in ALS, which could aetiologically
link this disease and PA through exacerbation of
pathogenic abnormalities in homeostasis or a sim-
ultaneous predisposition to ALS and PA, though
conversely could just represent the consequences of
activity participation (21,37). Further work is
needed to determine the mechanisms of this poten-
tial indirect association, particularly the timing of
homeostatic variations in relation to disease onset.
The recent work by Huisman, Pupillo and
Hamidou represent important contributions to
understanding associations between ALS and PA,
but may lead some to conclude that this research
question has already been answered (15,16,31).
However, all previous studies on this topic, includ-
ing the current one, highlight the challenges of a
case-control study design imposed by the rarity of
ALS, but we propose that this report represents a
rational approach when examining environmental
exposure associations with rare diseases of unknown
latency period. We chose to focus on using a
specifically designed and validated questionnaire,
able to rank individuals according to their activity
levels (23). Although alternative PA questionnaires
exist, few measure historical PA, with HAPAQ being
the first to be validated against repeated historical
objective activity measurements. Administration of
HAPAQ through individual, standardised face-to-
face interviews, using a life calendar based on key
life events to aid recall, facilitated complete, accur-
ate data collection. This represents a unique
approach not previously reported in other studies
on this topic, contrasting with methodology using
non-validated postal questionnaires, whose main
advantage is the ability to achieve large recruitment
samples. Other strengths of the present study
include clear case definition using established diag-
nostic criteria, and the recruitment of controls from
a similar general practice patient source from which
ALS cases were derived.
Interpretation of the results should be made
whilst considering potential limitations of this study.
As the role of C9ORF72 mutations in ALS
382 C. A. Harwood et al.
pathogenesis had not been recognised at the time
this study was initiated, participant genotyping was
not routinely undertaken as the percentage of
sporadic ALS cases with mutations in known sus-
ceptibility genes was estimated to be minimal.
However, DNA samples were collected and stored
from the majority of study participants, thus
facilitating future examination of potential gene-
environment interactions.
Retrospective data collection risks differential
recall of exposures, with cases potentially over-
estimating activity levels, particularly if they were
aware of the proposed association. To minimise this,
all participants were blinded to the research hypoth-
esis and uncertainty regarding any association
between ALS and PA was made clear during each
interview. The social desirability of exercise makes
PA overestimation a possibility, potentially biasing
the result towards the null if it was non-differential
by case status, but could bias results in either
direction if it was not. The previously reported
under- and over-reporting of PA in active and more
sedentary individuals, respectively, by HAPAQ
would have similar effects (23).
The focus on PA and the social desirability of
this behaviour may have attracted more active
controls to participate in the study, risking selection
bias. However, this direction of bias would reduce
the size of the disease association detected. An
acceptable recruitment rate was achieved (71.7%)
from invited cases, though case ascertainment for
the geographically defined recruitment population
was incomplete. Although only partial data were
available regarding eligible cases who declined
participation, characteristics of recruited cases
were comparable to the general ALS population,
suggesting a representative case sample. Although
interviewers were not blinded to the participants’
disease status, HAPAQ was administered in a
structured manner dictated by time periods, ensur-
ing standardised data collection for all participants
and minimising interviewer bias.
HAPAQ was validated using a mixed gender
population of comparable average age to the par-
ticipants in the present study. However, participants
in the validation sample were not defined by a
neurological disease such as ALS and it is possible
that ALS patients may recall PA differently. Also,
HAPAQ validity was established only for the most
recent 15 years. However, this does represent a
historical timeframe and identical questions were
repeated throughout each questionnaire time
period. A prospective cohort study design with
very long follow-up time and repeated assessment
of PA before occurrence of ALS would eliminate
many of the limitations already discussed. However,
given the rarity of ALS, very few existing cohort
studies will have the potential to answer this
research question.
In summary, this study suggests a positive
association between PA and the development of
sporadic ALS using validated methodology.
Although ORs approximate percentage risk with
rare diseases, the contribution of PA to the risk of
ALS within this study population can only be
quantified by understanding the relevant gene-
environment interaction. With individual risk likely
to be dictated by inherent genetic predisposition,
identifying this susceptibility is imperative if advice
regarding lifestyle modification is to be given,
particularly given the established health benefits of
PA (38,39). Establishing the genetic interaction
would clarify whether PA represents a direct ALS
risk factor or a proxy for one or more specific
genotypes through which propensity to athleticism
and ALS are both expressed.
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